Glenville, NY – Fiorello Pharmaceuticals, Inc., a pharmaceutical company dedicated to aiding patients with painful and life-threatening conditions, announced today that it has earned registered organization status from the New York State Department of Health to operate a medical marijuana company. The company will immediately begin work on a state-of-the-art medical marijuana cultivation and manufacturing facility in the Town of Glenville in Schenectady County.
The Glenville facility will be located in a former Navy Depot building now part of the Glenville Business & Technology Park. The facility will undergo renovations and will be the base of operations for the pharmaceutical company. Fiorello will cultivate and then manufacture marijuana-based pharmaceutical products at the highly secure site. The company plans to hire a number of management, research, and technology employees from the local community, creating many new jobs in Schenectady County.
Anthony Jasenski, Chairman of the Schenectady County Legislature said, “The Schenectady County Legislature was proud to support Fiorello’s license application and we thank Governor Cuomo and the Department of Health for approving this project that brings another new business to Schenectady County. This is a great new use for a former Navy Depot building and we are excited about bringing a cutting-edge pharmaceutical company to our community that will help patients throughout the State while creating jobs for our residents.”
Glenville Town Supervisor Chris Koetzle said, “Glenville is pleased that the thorough and professional team at Fiorello Pharmaceuticals has been awarded a license and will begin operations at the Glenville Business & Technology Park. This will create jobs and new professional development opportunities for Town residents, while continuing the great progress we have seen in bringing new companies to the business park. Glenville continues to build tax base and jobs and we congratulate the Fiorello team for getting this well-deserved approval from New York State.”
About Fiorello Pharmaceuticals
The mission of Fiorello Pharmaceuticals, Inc. is to provide patients suffering from debilitating and life-threatening illnesses with compassionate service and access to high-quality medical marijuana from trained medical professionals. Fiorello aspires to advance scientific understanding, clinical care, and patient education by incorporating medical and pharmaceutical industry best practices into research, development, and education. The name “Fiorello” — Italian for “little flower” — honors legendary New York City Mayor Fiorello H. LaGuardia, who maintained a deep commitment to medical science and the benefits of medical marijuana.
For More Information
CONTACT: Don Reisinger